Expression of c-KIT and SCF has been reported in patient-derived immortalized colorectal cancer cell lines [121] and in premalignant and malignant colonic lesions, where c-KIT and SCF co-expression has been associated with a worse clinical outcome [122]. This evidence concerns the gene KITLG and colorectal cancer.